Bibliographic information
GuidelineWHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Maintained
Surgery for patients on MDR/RR-TB treatment: In patients with rifampicin-resistant tuberculosis (RR-TB) or multidrug-resistant TB (MDR-TB), elective partial lung resection (lobectomy or wedge resection) may be used alongside a recommended MDR-TB regimen.
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
Year2016
Institution
Guideline
WHO consolidated guidelines on drug-resistant tuberculosis treatment
Year2019
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWHO